07/09/2012
Anapharm Europe validates new LC/MS/MS bioanalytical method for Tiotropium
Anapharm Europe has successfully developed and validated a bioanalytical method for determination of Tiotropium in human plasma by LC/MS/MS. This method with a Limit of Quantification as low as 0.5 pg/mL adds to the list of high sensitivity methods for inhalers, including Fluticasone and Salmeterol.
MORE NEWS
Anapharm Bioanalytics’ successful FDA Inspection
Anapharm Bioanalytics is proud to announce that it has successfully undergone another US FDA inspection at its Barcelona based bioanalytical lab. The inspection, that took place in June 2019, had a focus on a total of 8 studies. This was the second unannounced FDA inspection at our facilities without any observations; no 483 form issued.
READ MOREAnapharm Bioanalytics has been acredited under the Gulf Health Council
Anapharm Bioanalytics is proud to announce that it has been recently added to the List of Bioequivalence Centres Approved by GCC, Gulf Cooperation Council (United Arab Emirates, Bahrain, Kingdom of Saudi Arabia, Sultanate of Oman, Qatar, Kuwait and Republic of Yemen).
READ MOREAnapharm Bioanalytics Brazilian ANVISA Certificate Renewal
Anapharm Bioanalytics is proud to announce that it has recently renewed its ANVISA (Brazil) certificate.
The renewed certification is valid until 11th June 2020.